Drugs / DWC202212
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05699070 | Feb → Apr 2023 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWC202212 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05699070 ↗ |